Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Go back to Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
(NASDAQ: RANI) Delayed: 0.74 -0.03 (3.9%)
Previous Close $0.77    52 Week High
Open $0.79    52 Week Low
Day High $0.79    P/E N/A 
Day Low $0.73    EPS
Volume 460,233